144 related articles for article (PubMed ID: 22018489)
1. Heat shock factor 1 upregulates transcription of Epstein-Barr Virus nuclear antigen 1 by binding to a heat shock element within the BamHI-Q promoter.
Wang FW; Wu XR; Liu WJ; Liao YJ; Lin S; Zong YS; Zeng MS; Zeng YX; Mai SJ; Xie D
Virology; 2011 Dec; 421(2):184-91. PubMed ID: 22018489
[TBL] [Abstract][Full Text] [Related]
2. Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency.
Schaefer BC; Paulson E; Strominger JL; Speck SH
Mol Cell Biol; 1997 Feb; 17(2):873-86. PubMed ID: 9001242
[TBL] [Abstract][Full Text] [Related]
3. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity.
Chen H; Lee JM; Wang Y; Huang DP; Ambinder RF; Hayward SD
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9339-44. PubMed ID: 10430944
[TBL] [Abstract][Full Text] [Related]
4. Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection.
Zetterberg H; Stenglein M; Jansson A; Ricksten A; Rymo L
J Gen Virol; 1999 Feb; 80 ( Pt 2)():457-466. PubMed ID: 10073708
[TBL] [Abstract][Full Text] [Related]
5. Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency.
Zhang L; Pagano JS
Mol Cell Biol; 1999 Apr; 19(4):3216-23. PubMed ID: 10082588
[TBL] [Abstract][Full Text] [Related]
6. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
Lear AL; Rowe M; Kurilla MG; Lee S; Henderson S; Kieff E; Rickinson AB
J Virol; 1992 Dec; 66(12):7461-8. PubMed ID: 1331531
[TBL] [Abstract][Full Text] [Related]
7. Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells.
Schlager S; Speck SH; Woisetschläger M
J Virol; 1996 Jun; 70(6):3561-70. PubMed ID: 8648690
[TBL] [Abstract][Full Text] [Related]
8. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
[TBL] [Abstract][Full Text] [Related]
9. A simple reverse transcriptase PCR assay to distinguish EBNA1 gene transcripts associated with type I and II latency from those arising during induction of the viral lytic cycle.
Schaefer BC; Strominger JL; Speck SH
J Virol; 1996 Nov; 70(11):8204-8. PubMed ID: 8892954
[TBL] [Abstract][Full Text] [Related]
10. HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus.
Dheekollu J; Wiedmer A; Sentana-Lledo D; Cassel J; Messick T; Lieberman PM
J Virol; 2016 Jun; 90(11):5353-5367. PubMed ID: 27009953
[TBL] [Abstract][Full Text] [Related]
11. Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1.
Zhang L; Pagano JS
J Virol; 2000 Feb; 74(3):1061-8. PubMed ID: 10627515
[TBL] [Abstract][Full Text] [Related]
12. RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes.
Wang C; Li D; Zhang L; Jiang S; Liang J; Narita Y; Hou I; Zhong Q; Zheng Z; Xiao H; Gewurz BE; Teng M; Zhao B
J Virol; 2019 Jul; 93(13):. PubMed ID: 31019051
[TBL] [Abstract][Full Text] [Related]
13. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
14. Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection.
Yoshioka M; Kikuta H; Ishiguro N; Ma X; Kobayashi K
J Gen Virol; 2003 May; 84(Pt 5):1133-1140. PubMed ID: 12692278
[TBL] [Abstract][Full Text] [Related]
15. E2F1, ARID3A/Bright and Oct-2 factors bind to the Epstein-Barr virus C promoter, EBNA1 and oriP, participating in long-distance promoter-enhancer interactions.
Boreström C; Forsman A; Rüetschi U; Rymo L
J Gen Virol; 2012 May; 93(Pt 5):1065-1075. PubMed ID: 22302879
[TBL] [Abstract][Full Text] [Related]
16. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
[TBL] [Abstract][Full Text] [Related]
17. CTCF prevents the epigenetic drift of EBV latency promoter Qp.
Tempera I; Wiedmer A; Dheekollu J; Lieberman PM
PLoS Pathog; 2010 Aug; 6(8):e1001048. PubMed ID: 20730088
[TBL] [Abstract][Full Text] [Related]
18. Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs.
Schaefer BC; Strominger JL; Speck SH
Mol Cell Biol; 1997 Jan; 17(1):364-77. PubMed ID: 8972217
[TBL] [Abstract][Full Text] [Related]
19. B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription.
Liu CD; Lee HL; Peng CW
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941781
[TBL] [Abstract][Full Text] [Related]
20. Activity of the EBNA1 promoter associated with lytic replication (Fp) in Epstein-Barr virus associated disorders.
Brink AA; Meijer CJ; Nicholls JM; Middeldorp JM; van den Brule AJ
Mol Pathol; 2001 Apr; 54(2):98-102. PubMed ID: 11322171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
